DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment-- DiaMedica Therapeutics said Wednesday it began phase 2/3 testing of its DM199 drug candidate for the treatment of acute ischemic stroke with the dosing of first patient. The company expects to...